NCT06128694 2024-07-30
Effect of NUTRICAN to Improve Nutritional Status in Cancer Patients
Kalbe International Pte. Ltd
Phase 3 Unknown
Clinical Trials
79 trialsNCT05189028 2024-02-06
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
Phase 3 Unknown
NCT05446324 2023-12-01
SENGA
UMC Utrecht
Phase 3 Unknown
NCT02584478 2023-11-08
AL3818
Advenchen Laboratories, LLC
Phase 3 Unknown
NCT04596800 2023-10-31
PROPER
Instituto Brasileiro de Controle do Cancer
Phase 3 Unknown
NCT00411138 2023-10-11
PORTEC-3
Leiden University Medical Center
Phase 3 Unknown
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT03705156 2023-04-13
Clinical Trial Evaluating the Efficacy and Safety of ZL-2306 (Niraparib) in Ovarian Cancer Patient
Zai Lab (Hong Kong), Ltd.
Phase 3 Unknown
NCT04792749 2023-04-13
Clinical Effects of Metformin on Fertility-sparing Treatment for Early Endometrial Cancer
Samsung Medical Center
Phase 3 Unknown
NCT00326456 2023-03-27
MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer
National Cancer Institute, Naples
Phase 3 Unknown
NCT00660842 2023-03-24
MITO-7
National Cancer Institute, Naples
Phase 3 Unknown
NCT01802749 2023-03-24
MITO16MANGO2b
National Cancer Institute, Naples
Phase 3 Unknown
NCT05446883 2022-11-30
QL1706 Plus Chemotherapy±Bevacizumab for the First-Line Treatment of Persistent, Recurrent or Metastatic Cervical Cancer
Qilu Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT05622890 2022-11-21
A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.
Phase 3 Unknown
NCT03278717 2022-09-27
ICON9
University College, London
Phase 3 Unknown
NCT05043402 2022-08-15
A Study of Navicixizumab in Patients With Platinum Resistant Ovarian Cancer
OncXerna Theraputics, Inc.
Phase 3 Unknown
NCT04484415 2022-08-12
APRICITY
Jiangsu Yahong Meditech Co., Ltd aka Asieris
Phase 3 Unknown
NCT03703271 2022-07-18
Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia
Women's Hospital School Of Medicine Zhejiang University
Phase 3 Unknown
NCT02639650 2022-06-03
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
Women's Hospital School Of Medicine Zhejiang University
Phase 3 Unknown
NCT04756713 2022-05-27
ReCure
Brigham and Women's Hospital
Phase 3 Unknown
NCT04229615 2022-04-25
A Study of Fluzoparib±Apatinib Versus Placebo Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on First-Line Platinum-Based Chemotherapy
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT03955367 2022-02-23
Pelvic RT Versus Prophylactic Extended-field RT in Patients With Cervical Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT05244811 2022-02-17
Treat of Functional Ovarian Cysts by Compare Between Cocs and Progesterone Only Pills
Sohag University
Phase 3 Unknown
NCT05145218 2021-12-08
A Clinical Study of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsules Versus Paclitaxel as Weekly Treatment of Relapsed Platinum-resistant Ovarian Cancer
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 3 Unknown
NCT00942357 2021-10-19
Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer
GOG Foundation
Phase 3 Unknown
NCT00108745 2021-09-30
Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer
GOG Foundation
Phase 3 Unknown
NCT00954174 2021-09-30
Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity Cancer
GOG Foundation
Phase 3 Unknown
NCT04679064 2021-08-27
NItCHE-MITO33
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Phase 3 Unknown
NCT04885270 2021-08-10
Paclitaxel i.v. Plus Cisplatin i.p for NACT in Patients With Advanced Ovarian Cancer
West China Second University Hospital
Phase 3 Unknown
NCT01611766 2021-06-10
Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?
Shanghai Gynecologic Oncology Group
Phase 3 Unknown
NCT03709316 2021-06-02
A Study of ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer
Zai Lab (Hong Kong), Ltd.
Phase 3 Unknown
NCT04337632 2021-04-08
Evaluation of the Sensitivity to Different Chemotherapy Regimens in Platinum-Partial Sensitive Recurrent Ovarian Cancer
Hunan Cancer Hospital
Phase 3 Unknown
NCT04646954 2020-11-30
DNA Methylation Testing for the Screening of Uterine Cervical Lesion
Peking Union Medical College Hospital
Phase 3 Unknown
NCT03912415 2020-09-18
FERMATA
Biocad
Phase 3 Unknown
NCT04473339 2020-09-09
A Randomized Prospective Trail of HIPEC in Recurrent Ovarian Cancer Patients With HRR Mutation
Zhongnan Hospital
Phase 3 Unknown
NCT01823315 2019-12-24
GTN-01
Huazhong University of Science and Technology
Phase 3 Unknown
NCT03693248 2019-12-10
ROCOCO
Seoul National University Hospital
Phase 3 Unknown
NCT03373058 2019-11-06
EHTASEOCCS
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT04000295 2019-10-08
Apatinib and Etoposide Capsule Versus Weekly Paclitaxel in Patients With Platinum Resistant Ovarian Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 3 Unknown
NCT04101760 2019-10-08
Granulocyte Colony Stimulating Factor for for the Prevention of Febrile Neutropenia in Epithelial Ovarian Cancer
Peking Union Medical College Hospital
Phase 3 Unknown
NCT00806117 2019-07-30
STARS
Sun Yat-sen University
Phase 3 Unknown
NCT01561586 2019-02-27
TACO
Korea Cancer Center Hospital
Phase 3 Unknown
NCT03740464 2018-11-14
Long-acting G-CSF for Febrile Neutropenia
Peking Union Medical College Hospital
Phase 3 Unknown
NCT03162276 2018-09-07
Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers
Sheba Medical Center
Phase 3 Unknown
NCT02629718 2018-03-16
SYSGO-003
Sun Yat-sen University
Phase 3 Unknown
NCT00719303 2018-02-19
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
GOG Foundation
Phase 3 Unknown
NCT02669459 2018-02-06
TopIC-2
Erasmus Medical Center
Phase 3 Unknown
NCT03180177 2018-01-24
EHNPCTASEOC
Affiliated Cancer Hospital & Institute of Guangzhou Medical University
Phase 3 Unknown
NCT03332069 2017-11-07
mEHT
University of Witwatersrand, South Africa
Phase 3 Unknown
NCT02840331 2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3 Unknown